Irritable Bowel Syndrome  >>  Kremezin (AST-120)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kremezin (AST-120) / Mitsubishi Tanabe
NCT00583128 / 2007-001950-18: Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Completed
2
117
US, Europe
AST-120, Celphere® CP-305
Ocera Therapeutics
Irritable Bowel Syndrome
05/10
06/10

Download Options